Treatable traits and their application in high-, middle- and low-income countries

Vanessa M McDonald^{1

2

3

4}, Peter G Gibson^{1

2

3

4}

Affiliations

¹ National Health and Medical Research Council Centre of Excellence in Severe Asthma, Newcastle, NSW, Australia.
² Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia.
³ Viruses, Immunology, Vaccines, Asthma (VIVA) programme, Hunter Medical Research Institute, Newcastle, NSW, Australia.
⁴ Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia.

Free article

Vanessa M McDonald et al. Respirology. 2019 Oct.

Free article

. 2019 Oct;24(10):942-943.

doi: 10.1111/resp.13626. Epub 2019 Jun 20.

Vanessa M McDonald^{1

2

3

4}, Peter G Gibson^{1

2

3

4}

¹ National Health and Medical Research Council Centre of Excellence in Severe Asthma, Newcastle, NSW, Australia.
² Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia.
³ Viruses, Immunology, Vaccines, Asthma (VIVA) programme, Hunter Medical Research Institute, Newcastle, NSW, Australia.
⁴ Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia.

No abstract available

Keywords: asthma; chronic obstructive pulmonary disease; treatable traits.

References

1. World Health Organisation. Global status report on non communicable diseases. 2014. [Accessed 30 June 2019.] Available from URL: https://apps.who.int/iris/bitstream/handle/10665/148114/9789241564854_en...
1. Kirenga BJ, de Jong C, Mugenyi L, Katagira W, Muhofa A, Kamya MR, Boezen HM, van der Molen T. Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study. Thorax 2018; 73: 983-5.
1. World Health Organisation. Disease burden and mortality estimates. 2016. [Accessed 17 May 2019.] Available from URL: https://www.who.int/healthinfo/global_burden_disease/estimates/en/
1. McDonald VM, Fingleton J, Agusti A, Hiles SA, Clark VL, Holland AE, Marks GB, Bardin PP, Beasley R, Pavord ID et al. Treatable traits: a new paradigm for 21st century management of chronic airway diseases. Eur. Respir. J. 2019; 53: pii: 1802058.
1. Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, Humbert M, Jones P, Gibson PG, Vestbo J et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur. Respir. J. 2016; 47: 410-9.